IGNOU, WHO launch healthcare waste management certification, enrolment open
The Indira Gandhi National Open University (IGNOU), in partnership with the World Health Organization (WHO) for the South-East Asia Region, has rolled out a Certificate in Health Care Waste Management (CHCWM). This initiative is poised to bolster public health infrastructures and safeguard the environment by equipping professionals to manage biomedical waste proficiently.The CHCWM programme confronts the dangers to health and ecology posed by inadequate disposal of medical waste. It seeks to educate both professionals and paraprofessionals engaged in hospitals, primary health centres, and waste management sectors. The curriculum aligns with India's Bio-Medical Waste Management Rules, 2016, and adheres to WHO's international standards.advertisementPARTICIPANTS AND COURSE STRUCTURECourse enrollees will delve into the various kinds of healthcare waste and their effects on public and environmental health. The curriculum emphasises infection control, legal statutes, and tailored regional practices, with a strong focus on practical application.
Students can complete the programme in a span ranging from six months to two years, with enrolments opening twice annually -- January to June or July to December.To qualify, candidates must have finished Class 12 or an equivalent.The programme leverages a blended learning format, incorporating Self-Instructional Materials (SIMs), live online sessions, instructional videos, and engaging Q&A forums.The flexible curriculum lets students choose between a workshop or a project alongside theoretical modules. Evaluation is through assignments and a term-end examination.ADMISSIONS PROCESS VIA SAMARTHAdmissions for the CHCWM course are currently available. Prospective students can apply through the Samarth portal at ignouadmission.samarth.edu.in.advertisementThe Samarth system is a comprehensive digital platform utilised by IGNOU and others to simplify the admissions process, ensuring a smooth user experience.Within the Samarth portal, applicants can complete registration, submit application forms, upload necessary documents, and settle fees -- all digitally.This system supports application tracking and provides automated updates on application status and necessary steps, making the admissions process seamless across IGNOU's various programmes.Alongside the CHCWM programme, IGNOU has also unveiled its inaugural master's programme in Home Science, reflecting its dedication to broadening educational avenues across different fields.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Indian Express
18 minutes ago
- Indian Express
A new Covid variant Nimbus aka ‘razor blade throat' is on the rise. All you need to know
India is witnessing a fresh uptick in COVID-19 cases, with over 7,000 active infections and more than 70 deaths reported recently. While SARS-CoV-2 has become a recurring seasonal presence, much like influenza, a new variant, NB.1.8.1, nicknamed 'Nimbus', is drawing global attention for its unusually painful symptom: a sore throat that some are describing as feeling like 'razor blades.' Indian doctors confirm that a few patients have reported this distressing feature. Where has the Nimbus spread? The NB.1.8.1 variant has spread rapidly across China and Hong Kong, and cases have now been detected in several US states, including California, Washington, Virginia, and New York, according to an Associated Press report. Australia has also recorded cases. In the UK, 13 cases were confirmed in June, accompanied by a nearly 10 per cent rise in hospitalisations, The Independent reported. The variant and symptoms have also been detected in India. By mid-May, NB.1.8.1 accounted for nearly 11 per cent of all sequenced COVID samples globally, signaling a rapid rise in circulation. What are the symptoms? The most reported and defining symptom of the Nimbus variant is a severely painful sore throat. Other symptoms include fever, chills, cough, shortness of breath, and loss of taste or smell. However, the World Health Organization (WHO) has stated that the variant does not appear to cause more severe illness than previous strains and is currently considered low risk. What has WHO said? The WHO has classified NB.1.8.1 as a 'variant under monitoring,' indicating that while it is spreading, it doesn't yet pose a major threat. The organisation has also confirmed that current COVID-19 vaccines remain effective in preventing severe outcomes linked to the variant. 'The WHO assesses the additional risk to the global public as currently low, and existing COVID-19 vaccines are considered effective in preventing severe disease,' Dr Naveed Asif, a general practitioner at The London General Practice, told The Independent. Which vaccines offer protection? Vaccines approved by the US FDA – Moderna, Pfizer-BioNTech, and Novavax – are expected to be effective against NB.1.8.1, especially because it belongs to the Omicron JN.1 lineage. An article by New York-Presbyterian/Columbia University Irving Medical Center stresses the importance of staying up-to-date with boosters. Those with underlying health conditions like diabetes, heart disease, or hypertension should take extra precautions, as their immune response may not be as robust. Why Nimbus spreads faster Scientists believe NB.1.8.1 may spread more efficiently due to stronger binding with human cells. A Gavi report noted that the variant binds tightly to the ACE2 receptor, which SARS-CoV-2 uses to enter the body. 'Using lab-based models, researchers found NB.1.8.1 had the strongest binding affinity to the human ACE2 receptor of several variants tested,' said virologist Lara Herrero from Griffith University in The Conversation, 'suggesting it may infect cells more efficiently than earlier strains.' Dr Chun Tang, a general practitioner at UK-based Pall Mall Medical, added that while the variant isn't drastically different from Omicron, 'some tweaks to its spike protein' may make it more transmissible or help it evade immunity. 'What sets NB.1.8.1 apart is how quickly it spreads,' said Dr Magdalena Sobieszczyk, Chief of Infectious Diseases at New York-Presbyterian/Columbia. 'It has a genetic advantage: mutations that make it easy for it to bind to receptors on human cells.' Prevention is key Precautions remain largely the same. Mask up in crowded places, cover your mouth while coughing or sneezing, wash and sanitise your hands regularly, and avoid stepping out if unwell. Ventilated spaces remain safer, especially during spikes in transmission. No, 'Nimbus' isn't a Harry Potter reference While some may associate 'Nimbus' with the magical broomstick from 'Harry Potter' or characters from 'Rick and Morty', the nickname actually refers to a type of cloud. Professor T Ryan Gregory of the University of Guelph in Canada explained to Gavi' that naming conventions like 'Nimbus' (NB.1.8.1) and 'Stratus' (XFG) help make emerging variants easier to track and communicate to the public.
India Today
5 hours ago
- India Today
IGNOU, WHO launch healthcare waste management certification, enrolment open
The Indira Gandhi National Open University (IGNOU), in partnership with the World Health Organization (WHO) for the South-East Asia Region, has rolled out a Certificate in Health Care Waste Management (CHCWM). This initiative is poised to bolster public health infrastructures and safeguard the environment by equipping professionals to manage biomedical waste CHCWM programme confronts the dangers to health and ecology posed by inadequate disposal of medical waste. It seeks to educate both professionals and paraprofessionals engaged in hospitals, primary health centres, and waste management sectors. The curriculum aligns with India's Bio-Medical Waste Management Rules, 2016, and adheres to WHO's international AND COURSE STRUCTURECourse enrollees will delve into the various kinds of healthcare waste and their effects on public and environmental health. The curriculum emphasises infection control, legal statutes, and tailored regional practices, with a strong focus on practical application. Students can complete the programme in a span ranging from six months to two years, with enrolments opening twice annually -- January to June or July to qualify, candidates must have finished Class 12 or an programme leverages a blended learning format, incorporating Self-Instructional Materials (SIMs), live online sessions, instructional videos, and engaging Q&A flexible curriculum lets students choose between a workshop or a project alongside theoretical modules. Evaluation is through assignments and a term-end PROCESS VIA SAMARTHAdmissions for the CHCWM course are currently available. Prospective students can apply through the Samarth portal at Samarth system is a comprehensive digital platform utilised by IGNOU and others to simplify the admissions process, ensuring a smooth user the Samarth portal, applicants can complete registration, submit application forms, upload necessary documents, and settle fees -- all system supports application tracking and provides automated updates on application status and necessary steps, making the admissions process seamless across IGNOU's various the CHCWM programme, IGNOU has also unveiled its inaugural master's programme in Home Science, reflecting its dedication to broadening educational avenues across different fields.
Economic Times
6 hours ago
- Economic Times
New Covid variant 'Nimbus': Symptoms, vaccine response, and why it causes painful 'razor blade throat'
New Covid variant Nimbus symptoms: A new Covid-19 variant, NB.1.8.1, nicknamed "Nimbus," is spreading globally, including in the US and Asia. While more transmissible, it doesn't appear more dangerous. A key symptom is a severe sore throat, described as "razor blade throat," alongside typical symptoms like congestion, fatigue, and fever. Tired of too many ads? Remove Ads What Is the New Covid Variant Nimbus Symptom? New Covid Variant Nimbus: What Are Other Symptoms? Nasal congestion or a runny nose Fatigue Mild cough Fever Muscle or body aches Headaches Diarrhoea Nausea or vomiting Loss of taste or smell Shortness of breath New Covid Variant Nimbus: How Is It Different? Tired of too many ads? Remove Ads New Covid Variant Nimbus: Should You Be Worried? Spread across regions and airports New Covid Variant Nimbus: What WHO is saying? New Covid Variant Nimbus Vaccines ( Originally published on Jun 18, 2025 ) A new Covid-19 variant known as NB.1.8.1, or informally 'Nimbus,' is spreading across parts of the United States and Asia. The World Health Organization (WHO) said on May 28 that the rise in cases has been seen mainly in the eastern Mediterranean, Southeast Asia, and western Pacific regions. While the variant is believed to spread more easily, it does not appear to cause more severe illness compared to previous of the most talked-about symptoms of the Nimbus variant is a very painful sore throat, often called " razor blade throat ". People have described the feeling as similar to swallowing glass or razor blades. Reports suggest that this symptom appears to be more intense than those caused by earlier variantsPeople infected with the Nimbus variant have also reported the following symptoms:Less commonly, some patients are also experiencing:Doctors say that the main difference with this variant is the severity of the sore throat. While past variants also caused throat pain, this one seems to cause more intense discomfort. The sore throat comes from irritation caused by infection in the throat's many experts believe the overall set of symptoms still matches those of previous Covid-19 far, there is no strong evidence that Nimbus leads to more serious illness. But those who are unvaccinated or immunocompromised might still face higher risks, especially for breathing variant made up nearly 11% of globally sequenced samples by mid-May, according to WHO. U.S. airport screenings detected the variant in travellers arriving from affected regions into California, Washington, Virginia, and New WHO has said that although some western Pacific countries have reported more Covid cases and hospitalizations, there is no current evidence showing that the Nimbus variant causes more severe WHO has classified Nimbus as a 'variant under monitoring' and stated that it poses a low risk to global public health. Existing Covid-19 vaccines are expected to remain effective against Secretary Robert F. Kennedy Jr. said last month that Covid-19 shots are no longer recommended for healthy children and pregnant women. The announcement was immediately questioned by several public health experts.(Inputs from agencies)
